Good outcome of liver transplantation in patients with pre-existing renal cell carcinoma.

Liver Transplantation Renal Clear Cell Carcinoma Solid Tumor mTOR inhibitor

Journal

Clinics and research in hepatology and gastroenterology
ISSN: 2210-741X
Titre abrégé: Clin Res Hepatol Gastroenterol
Pays: France
ID NLM: 101553659

Informations de publication

Date de publication:
13 Dec 2023
Historique:
received: 12 12 2023
accepted: 12 12 2023
medline: 16 12 2023
pubmed: 16 12 2023
entrez: 15 12 2023
Statut: aheadofprint

Résumé

The presence of a pre-existing or recent extra-hepatic solid tumor was considered for a long time as an absolute contraindication to liver transplantation, by fear of futility with an unacceptable increase in non-liver-related mortality. However, cancer-related mortality in solid malignancies is heterogeneous, and experts suggest that case-by-case multidisciplinary decisions should be made. Here, we report the cases of 3 patients with favorable oncological and liver outcome in patients with renal cell carcinoma detected during pre-transplant evaluation that nonetheless underwent liver transplantation.

Identifiants

pubmed: 38101698
pii: S2210-7401(23)00191-2
doi: 10.1016/j.clinre.2023.102266
pii:
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

102266

Informations de copyright

Copyright © 2023. Published by Elsevier Masson SAS.

Déclaration de conflit d'intérêts

Declaration of Competing Interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

G Lassailly (G)

CHU Lille, Hôpital Huriez, Maladies de l'Appareil Digestif, Lille, France.

M Ningarhari (M)

CHU Lille, Hôpital Huriez, Maladies de l'Appareil Digestif, Lille, France.

J Dumortier (J)

Fédération des Spécialités Digestives, Hôpital Edouard Herriot, Hospices civils de Lyon, et Université Claude Bernard Lyon 1.

C Lafforgue (C)

CHU Lille, Hôpital Huriez, Maladies de l'Appareil Digestif, Lille, France.

S Bouye (S)

CHU Lille, Hôpital Huriez, Urologie, Lille, France.

M El Amrani (ME)

CHU Lille, Hôpital Huriez, Chirurgie Digestive et Transplantations, Lille, France.

G Lebuffe (G)

CHU Lille, Hôpital Huriez, Chirurgie Digestive et Transplantations, Lille, France.

A Villers (A)

CHU Lille, Hôpital Huriez, Urologie, Lille, France.

S Truant (S)

CHU Lille, Hôpital Huriez, Chirurgie Digestive et Transplantations, Lille, France.

P Mathurin (P)

CHU Lille, Hôpital Huriez, Maladies de l'Appareil Digestif, Lille, France.

A Louvet (A)

CHU Lille, Hôpital Huriez, Maladies de l'Appareil Digestif, Lille, France.

O Boillot (O)

Fédération des Spécialités Digestives, Hôpital Edouard Herriot, Hospices civils de Lyon, et Université Claude Bernard Lyon 1.

E Boleslawski (E)

Fédération des Spécialités Digestives, Hôpital Edouard Herriot, Hospices civils de Lyon, et Université Claude Bernard Lyon 1.

S Dharancy (S)

CHU Lille, Hôpital Huriez, Maladies de l'Appareil Digestif, Lille, France. Electronic address: sebastien.dharancy@chru-lille.fr.

Classifications MeSH